Clinical Trials on Hypoparathyroidism Postprocedural in Finland

Total 4 results

Shire

Completed

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

Hypoparathyroidism

United States
Shire

Completed

A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

Hypoparathyroidism

United States
Shire

Completed

Use of NPSP558 in the Treatment of Hypoparathyroidism (REPLACE)

Hypoparathyroidism

United States, Denmark, Canada, Hungary, United Kingdom, Belgium, France, Italy
Takeda
Takeda Development Center Americas, Inc.

Active, not recruiting

A Registry for Participants With Chronic Hypoparathyroidism (PARADIGHM)

Hypoparathyroidism

United States, Spain, Denmark, Germany, Austria, Canada, Greece, Sweden, Italy, Norway, United Kingdom

3

Subscribe